It appears you have not yet Signed Up with our community. To Sign Up for free, please click here....



Message Board
THIS MESSAGE BOARD IS NO LONGER ACTIVE. TO SEE OUR ACTIVE MESSAGE BOARDS, PLEASE GO HERE





Message
Posted by Bruxe on September 07, 2000 at 09:34:29:

In Reply to: POTENTIAL PARKINSON'S DISEASE posted by Bruce on September 07, 2000 at 00:51:55:

: This info. was published by the NPF. Compounds with a number of similar analogs called neuroimmunophilin ligands have been successfully tested in rats and mice without turning up any problems with toxicity or side effects. The drug works by regenerating damaged neurons, resulting in more than 90 % recovery of normal behavior in animal trials.The drug developed by Guilford Pharmaceuticals of Baltimore, represent a "tremendously exciting " advance says Dr. George Pincus, MD, a Parkinson's disease expert. Dr. Gregory Hamilton, the principal scientist, stated "What we're really excited about is that these compounds don't just slow down the progression of the disease." The animal trials suggest "we may be able to take patients who have begun to show the outward manifestations of Parkinson's disease and push them back over the threshold into normal behavioral fumction. We hope to reverse the disease and not simply slow it down." The drug is presently called GPI-1046. As we have been posted by Chuck and John, the "guinea pigs", the clinical trials on humans is taking place at Yale. Your courage will not be forgotten Omited the word "cure" from title

Follow Ups

All times are GMT -7. The time now is 02:58 PM.



Site owned and operated by HealthBoards.comô
Terms of Use © 1998-2014 HealthBoards.comô All rights reserved.
Do not copy or redistribute in any form!